Delivery Order SPE2DB22D2007-SPE2DB24FJ1GA
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albumin (Human) 5% IV Solution 250ML. The contract has a ceiling value of $2,511.60 and a performance period ending on July 28, 2025. The contract is not set aside and was awarded on July 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,080.40 and covers the delivery of albumin (human) 25% IV solution in 50 ml containers. This order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albumin (Human) 25% IV Solution, 100 milliliters, with a ceiling value of $4,992.48 and a completion date of July 28, 2025. The contract is a Firm Fixed Price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Albumin (Human) 5% IV Solution 250ML. The delivery order has a ceiling value of $3,139.50 and a performance period extending through May 29, 2025. This order is placed under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999.00 prime contract that provides a comprehensive global pharmaceutical support vehicle....
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albumin (Human) 25% IV Solution 50 mL, a medical product used in healthcare settings. The award has a ceiling value of $1,560.30 and a period of performance through July 15, 2025. This order is not associated with a set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of Albumin (Human) 5% IV Solution 250ml, with a ceiling value of $1,506.96 and a period of performance through February 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor and this award is associated with a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,511.60, is for the supply of Albumin (Human) 5% IV Solution 250ML. The contract has an ultimate completion date of April 2, 2025 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the procurement of Albumin (Human) 5% IV Solution 250ML, a critical medical product, with a ceiling value of $3,139.50 and an ultimate completion date of April 15, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Albumin (Human) 25% IV Solution in 50 mL vials. It is a Firm Fixed Price Delivery Order contract with a ceiling value of $1,040.20 and a completion date of July 25, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albumin (Human) 25% IV Solution 100 mL, a medical product, with a ceiling value of $2,080.20 and a period of performance through April 29, 2025. The contract is a firm fixed-price, non-set-aside delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ1GADelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564176790 - Albumin (Human) 5% IV Solution 250ML. The contract has a ceiling value of $1,214.00 and a period of performance through April 26, 2024. This is a single-award indefinite delivery contract (IDC) valued up to $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for providing these critical pharmaceutical items to support military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/5/24 |